Targeting the human serotonin transporter (hSERT) with quantum dots

被引:0
|
作者
Tomlinson, I. D. [1 ]
Chang, Jerry [1 ]
Iwamoto, Hideki [2 ]
De Felice, Louis J. [2 ,3 ]
Blakely, Randy D. [2 ,3 ]
Rosenthal, Sandra J. [1 ,2 ]
机构
[1] Vanderbilt Univ, Dept Chem, Stn B 311822, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA
关键词
quantum dots; serotonin; hSERT; antagonist; paroxetine;
D O I
10.1117/12.782801
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this paper we report our work on the development of a human serotonin transporter (hSERT) antagonist that can be conjugated to quantum dots. This approach has been used to target and visualize the human serotonin transporter protein (hSERT). We demonstrate that labeling is blocked by the addition of high affinity hSERT antagonists such as paroxetine. This approach may be useful for the development of fluorescent assays to study the location and temporal dynamics of biogenic amine transporters and also holds promise for the development of plate-based high throughput assays used to identify novel transporter antagonists.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Selective targeting of microglia by quantum dots
    S Sakura Minami
    Binggui Sun
    Ketul Popat
    Tiina Kauppinen
    Mike Pleiss
    Yungui Zhou
    Michael E Ward
    Paul Floreancig
    Lennart Mucke
    Tejal Desai
    Li Gan
    Journal of Neuroinflammation, 9
  • [22] Production and Targeting of Monovalent Quantum Dots
    Seo, Daeha
    Farlow, Justin
    Southard, Kade
    Jun, Young-wook
    Gartner, Zev J.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2014, (92):
  • [23] EXPLORING QSAR ANALYSIS OF CYCLOHEXANAMINE CLASS OF HUMAN SEROTONIN TRANSPORTERS (HSERT) INHIBITORY ACTIVITIES USING PHYSICOCHEMICAL PARAMETERS
    Shukla, N.
    Srivastava, A. K.
    OXIDATION COMMUNICATIONS, 2013, 36 (01): : 133 - 142
  • [24] Understanding of the Serotonin Transporter Mechanism-Targeting Drug Therapy
    Fassler, Amy
    Rens, Davis
    Shah, Ruhi
    Chojnacki, Kennan
    Rens, Kai
    FASEB JOURNAL, 2022, 36
  • [25] Induced fit, ensemble binding space docking and Monte Carlo simulations of MDMA 'ecstasy' and 3D pharmacophore design of MDMA derivatives on the human serotonin transporter (hSERT)
    Islas, Angel A.
    Moreno, Laura G.
    Scior, Thomas
    HELIYON, 2021, 7 (08)
  • [26] Brain serotonin transporter in human methamphetamine users
    Stephen J. Kish
    Paul S. Fitzmaurice
    Isabelle Boileau
    Gregory A. Schmunk
    Lee-Cyn Ang
    Yoshiaki Furukawa
    Li-Jan Chang
    Dennis J. Wickham
    Allan Sherwin
    Junchao Tong
    Psychopharmacology, 2009, 202
  • [27] INTERACTION OF FLUOXETINE WITH THE HUMAN PLACENTAL SEROTONIN TRANSPORTER
    COOL, DR
    LIEBACH, FH
    GANAPATHY, V
    BIOCHEMICAL PHARMACOLOGY, 1990, 40 (09) : 2161 - 2167
  • [28] Brain serotonin transporter in human methamphetamine users
    Kish, Stephen J.
    Fitzmaurice, Paul S.
    Boileau, Isabelle
    Schmunk, Gregory A.
    Ang, Lee-Cyn
    Furukawa, Yoshiaki
    Chang, Li-Jan
    Wickham, Dennis J.
    Sherwin, Allan
    Tong, Junchao
    PSYCHOPHARMACOLOGY, 2009, 202 (04) : 649 - 661
  • [29] Alternative splicing of the human serotonin transporter gene
    Bradley, CC
    Blakely, RD
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 (04) : 1356 - 1367
  • [30] Impact of oligomerization on the function of the human serotonin transporter
    Schmid, JA
    Just, H
    Sitte, HH
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2001, 29 : 732 - 736